 Todos Medical Ltd majority-owned subsidiary 3CL Pharma Ltd has reported a Day 26 update from an ongoing 60-day case study of the dietary supplement 3CL protease inhibitor Tollovid in a patient experiencing symptoms of long COVID. The patient, a 33-year-old man, originally contracted COVID-19 in March 2021 and experienced persistent long COVID symptoms, including significant weight loss, nausea and fatigue, the company said. 